These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 21433262)

  • 1. Macrovascular angiopathy in children and adolescents with type 1 diabetes.
    Giannini C; Mohn A; Chiarelli F; Kelnar CJ
    Diabetes Metab Res Rev; 2011 Jul; 27(5):436-60. PubMed ID: 21433262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eye complications and markers of morbidity and mortality in long-term type 1 diabetes.
    Grauslund J
    Acta Ophthalmol; 2011 Feb; 89 Thesis 1():1-19. PubMed ID: 21443578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history of cardiovascular disease in patients with diabetes: role of hyperglycemia.
    Milicevic Z; Raz I; Beattie SD; Campaigne BN; Sarwat S; Gromniak E; Kowalska I; Galic E; Tan M; Hanefeld M
    Diabetes Care; 2008 Feb; 31 Suppl 2():S155-60. PubMed ID: 18227478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Epidemiology of cardio-vascular complications of diabetes].
    Grimaldi A; Heurtier A
    Diabetes Metab; 1999 Jun; 25 Suppl 3():12-20. PubMed ID: 10421988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type 2 diabetes mellitus: a cardiovascular perspective.
    Varughese GI; Tomson J; Lip GY
    Int J Clin Pract; 2005 Jul; 59(7):798-816. PubMed ID: 15963208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular risk in the young type 1 diabetes population with a low 10-year, but high lifetime risk of cardiovascular disease.
    McVeigh GE; Gibson W; Hamilton PK
    Diabetes Obes Metab; 2013 Mar; 15(3):198-203. PubMed ID: 22998614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type 2 diabetes mellitus: prevention of macrovascular complications.
    Meeuwisse-Pasterkamp SH; van der Klauw MM; Wolffenbuttel BH
    Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):323-41. PubMed ID: 18327994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thiazolidinediones-benefits on microvascular complications of type 2 diabetes.
    Viberti G
    J Diabetes Complications; 2005; 19(3):168-77. PubMed ID: 15866064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial dysfunction and type 2 diabetes. Part 2: altered endothelial function and the effects of treatments in type 2 diabetes mellitus.
    Guerci B; Böhme P; Kearney-Schwartz A; Zannad F; Drouin P
    Diabetes Metab; 2001 Sep; 27(4 Pt 1):436-47. PubMed ID: 11547217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving macrovascular outcomes in type 2 diabetes: Outcome studies in cardiovascular risk and metabolic control.
    Schneider CA
    Curr Med Res Opin; 2006; 22 Suppl 2():S15-26. PubMed ID: 16914072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Type 2 diabetes mellitus and cardiovascular diseases: evaluation, treatment and prevention strategies].
    Mosseri MM; Fisman EZ; Tenenbaum A
    Harefuah; 2006 Feb; 145(2):141-6, 164. PubMed ID: 16509421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary prevention of cardiovascular disease in people with dysglycemia.
    Bianchi C; Miccoli R; Penno G; Del Prato S
    Diabetes Care; 2008 Feb; 31 Suppl 2():S208-14. PubMed ID: 18227487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early and intensive therapy for management of hyperglycemia and cardiovascular risk factors in patients with type 2 diabetes.
    Dailey G
    Clin Ther; 2011 Jun; 33(6):665-78. PubMed ID: 21704233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiologist's role in improving glucose control and global cardiovascular risk in patients with type 2 diabetes mellitus.
    Gotto AM
    Am J Cardiol; 2007 Feb; 99(4A):3B-5B. PubMed ID: 17307053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of cardiovascular complications in type 2 diabetes mellitus.
    Meigs JB
    Acta Diabetol; 2003 Dec; 40 Suppl 2():S358-61. PubMed ID: 14704869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From hyperglycemia to the risk of cardiovascular disease.
    Leiter LA
    Rev Cardiovasc Med; 2006; 7 Suppl 2():S3-9. PubMed ID: 17224875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycemic control and complications in type 2 diabetes mellitus.
    Stolar M
    Am J Med; 2010 Mar; 123(3 Suppl):S3-11. PubMed ID: 20206730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The early effects of elevated glucose on endothelial function as a target in the treatment of type 2 diabetes.
    Triggle CR
    Timely Top Med Cardiovasc Dis; 2008 Feb; 12():E3. PubMed ID: 18392213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of oral antihyperglycemic agents in modifying macrovascular risk factors in type 2 diabetes.
    Lebovitz HE
    Diabetes Care; 1999 Apr; 22 Suppl 3():C41-4. PubMed ID: 10189561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular disease in recent onset diabetes mellitus.
    Yamagishi S
    J Cardiol; 2011 May; 57(3):257-62. PubMed ID: 21367583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.